Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D09XSI
|
||||
| Former ID |
DNC014189
|
||||
| Drug Name |
9-O-[5-(Phenylol-1-yloxy)pentyl]berberine bromide
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [530625] | ||
| Formula |
C30H30BrNO5
|
||||
| Canonical SMILES |
COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC5=C(C=C4CC3)OCO5)OCCCC<br />COC6=CC=CC=C6.[Br-]
|
||||
| InChI |
1S/C30H30NO5.BrH/c1-32-27-11-10-21-16-26-24-18-29-28(35-20-36-29)17-22(24)12-13-31(26)19-25(21)30(27)34-15-7-3-6-14-33-23-8-4-2-5-9-23;/h2,4-5,8-11,16-19H,3,6-7,12-15,20H2,1H3;1H/q+1;/p-1
|
||||
| InChIKey |
WRLPRBPGJBAWDA-UHFFFAOYSA-M
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Cholinesterase | Target Info | Inhibitor | [530625] | |
| Acetylcholinesterase | Target Info | Inhibitor | [530625] | ||
| KEGG Pathway | Glycerophospholipid metabolism | ||||
| Cholinergic synapse | |||||
| PANTHER Pathway | Muscarinic acetylcholine receptor 1 and 3 signaling pathway | ||||
| Muscarinic acetylcholine receptor 2 and 4 signaling pathway | |||||
| Nicotinic acetylcholine receptor signaling pathwayP00042:Muscarinic acetylcholine receptor 1 and 3 signaling pathway | |||||
| Nicotinic acetylcholine receptor signaling pathway | |||||
| Pathway Interaction Database | ATF-2 transcription factor network | ||||
| PathWhiz Pathway | Phospholipid Biosynthesis | ||||
| References | |||||